Err–Cheng Chan
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
Papers in
-
- Microbial Metabolic Engineering and Bioproduction 7
- Surgery 27
- Orthopedic Infections and Treatments 13
- Orthopaedic implants and arthroplasty 10
- Helicobacter pylori-related gastroenterology studies 9
- Co-authors
- Shih‐Jung Liu (16 shared papers)Steve Wen‐Neng Ueng (14 shared papers)Chiuan-Chian Chiou (5 shared papers)Yung‐Bin Kuo (14 shared papers)Pi-Yueh Chang (2 shared papers)James T. Wu (2 shared papers)Kuo‐Chien Tsao (3 shared papers)Chung‐Wei Fan (10 shared papers)
- Journals
- Cancer Letters (6 papers)Biotechnology Letters (6 papers)Clinica Chimica Acta (5 papers)Journal of Medical Virology (4 papers)Applied Microbiology and Biotechnology (4 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Err–Cheng Chan
92 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 135
- Cancer Research 401
- Oncology 466
- Molecular Biology 973
- Biomaterials 163
- Pathology and Forensic Medicine 218
Countries citing papers authored by Err–Cheng Chan
This map shows the geographic impact of Err–Cheng Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Err–Cheng Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Err–Cheng Chan more than expected).
Fields of papers citing papers by Err–Cheng Chan
This network shows the impact of papers produced by Err–Cheng Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Err–Cheng Chan. The network helps show where Err–Cheng Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Err–Cheng Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 224 | |
| 2 | 2010 | 214 | |
| 3 | 2003 | 99 | |
| 4 | 2016 | 89 | |
| 5 | 2004 | 54 | |
| 6 | 2002 | 54 | |
| 7 | 2014 | 53 | |
| 8 | 1991 | 53 | |
| 9 | 2011 | 51 | |
| 10 | 2015 | 50 | |
| 11 | 2016 | 49 | |
| 12 | 2010 | 49 | |
| 13 | 2009 | 46 | |
| 14 | 2020 | 46 | |
| 15 | 2012 | 45 | |
| 16 | 2001 | 40 | |
| 17 | 1999 | 40 | |
| 18 | 2006 | 39 | |
| 19 | 2001 | 38 | |
| 20 | 1999 | 37 |
About Err–Cheng Chan
Err–Cheng Chan is a scholar working on Molecular Biology, Surgery, Epidemiology, Immunology and Oncology, having authored 92 papers that have together received 2.5k indexed citations. Recurring topics across this work include Orthopedic Infections and Treatments (13 papers), Orthopaedic implants and arthroplasty (10 papers), Helicobacter pylori-related gastroenterology studies (9 papers), Microbial Metabolic Engineering and Bioproduction (7 papers), Biofuel production and bioconversion (7 papers), Galectins and Cancer Biology (7 papers), Genetic factors in colorectal cancer (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Cancer Research (401 citations), Oncology (466 citations), Molecular Biology (973 citations), Biomaterials (163 citations) and Pathology and Forensic Medicine (218 citations). Err–Cheng Chan has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Shih‐Jung Liu, Steve Wen‐Neng Ueng, Chiuan-Chian Chiou, Yung‐Bin Kuo, Pi-Yueh Chang, James T. Wu, Kuo‐Chien Tsao, Chung‐Wei Fan, Tsu-Lan Wu and Jinn‐Shiun Chen. Their work appears in journals such as Cancer Letters, Biotechnology Letters, Clinica Chimica Acta, Journal of Medical Virology and Applied Microbiology and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.